These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9578489)

  • 1. The conversion of recombinant human mast cell prochymase to enzymatically active chymase by dipeptidyl peptidase I is inhibited by heparin and histamine.
    McEuen AR; Ashworth DM; Walls AF
    Eur J Biochem; 1998 Apr; 253(1):300-8. PubMed ID: 9578489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human prochymase activation. A novel role for heparin in zymogen processing.
    Murakami M; Karnik SS; Husain A
    J Biol Chem; 1995 Feb; 270(5):2218-23. PubMed ID: 7836453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel heparin-dependent processing pathway for human tryptase. Autocatalysis followed by activation with dipeptidyl peptidase I.
    Sakai K; Ren S; Schwartz LB
    J Clin Invest; 1996 Feb; 97(4):988-95. PubMed ID: 8613553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the activity of human chymase during storage and release from mast cells: the contributions of inorganic cations, pH, heparin and histamine.
    McEuen AR; Sharma B; Walls AF
    Biochim Biophys Acta; 1995 Jun; 1267(2-3):115-21. PubMed ID: 7612663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Processing of procarboxypeptidase A and other zymogens in murine mast cells.
    Dikov MM; Springman EB; Yeola S; Serafin WE
    J Biol Chem; 1994 Oct; 269(41):25897-904. PubMed ID: 7929294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two distinct forms of human mast cell chymase--differences in affinity for heparin and in distribution in skin, heart, and other tissues.
    McEuen AR; Gaça MD; Buckley MG; He S; Gore MG; Walls AF
    Eur J Biochem; 1998 Sep; 256(2):461-70. PubMed ID: 9760188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional reconstitution of an active recombinant human chymase from Pichia pastoris cell lysate.
    Nakakubo H; Morita M; Imada T; Takai S; Shiota N; Miyazaki M; Nakamura N
    Yeast; 2000 Nov; 16(15):1387-96. PubMed ID: 11054819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase.
    Saarinen J; Kalkkinen N; Welgus HG; Kovanen PT
    J Biol Chem; 1994 Jul; 269(27):18134-40. PubMed ID: 8027075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential inhibition of mast cell chymases by secretory leukocyte protease inhibitor.
    Pemberton AD; Huntley JF; Miller HR
    Biochim Biophys Acta; 1998 Jan; 1379(1):29-34. PubMed ID: 9468329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant expression of human mast cell proteases chymase and tryptase.
    Wang Z; Walter M; Selwood T; Rubin H; Schechter NM
    Biol Chem; 1998 Feb; 379(2):167-74. PubMed ID: 9524068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipeptide processing activates recombinant human prochymase.
    Urata H; Karnik SS; Graham RM; Husain A
    J Biol Chem; 1993 Nov; 268(32):24318-22. PubMed ID: 8226981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human mast-cell chymase: an improved procedure for expression in Pichia pastoris and purification of the highly active enzyme.
    Lockhart BE; Vencill JR; Felix CM; Johnson DA
    Biotechnol Appl Biochem; 2005 Feb; 41(Pt 1):89-95. PubMed ID: 15163313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended substrate specificity of rat mast cell protease 5, a rodent alpha-chymase with elastase-like primary specificity.
    Karlson U; Pejler G; Tomasini-Johansson B; Hellman L
    J Biol Chem; 2003 Oct; 278(41):39625-31. PubMed ID: 12900423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 2.2 A crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity.
    Pereira PJ; Wang ZM; Rubin H; Huber R; Bode W; Schechter NM; Strobl S
    J Mol Biol; 1999 Feb; 286(1):163-73. PubMed ID: 9931257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dog mast cell alpha-chymase activates progelatinase B by cleaving the Phe88-Gln89 and Phe91-Glu92 bonds of the catalytic domain.
    Fang KC; Raymond WW; Blount JL; Caughey GH
    J Biol Chem; 1997 Oct; 272(41):25628-35. PubMed ID: 9325284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of recombinant human chymase expressed in Escherichia coli.
    Takai S; Sumi S; Aoike M; Sakaguchi M; Itoh Y; Jin D; Matsumura E; Miyazaki M
    Jpn J Pharmacol; 2000 Feb; 82(2):144-9. PubMed ID: 10877533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibition of mast cell activation by neutrophil lactoferrin: uptake by mast cells and interaction with tryptase, chymase and cathepsin G.
    He S; McEuen AR; Blewett SA; Li P; Buckley MG; Leufkens P; Walls AF
    Biochem Pharmacol; 2003 Mar; 65(6):1007-15. PubMed ID: 12623133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptidyl peptidase I is essential for activation of mast cell chymases, but not tryptases, in mice.
    Wolters PJ; Pham CT; Muilenburg DJ; Ley TJ; Caughey GH
    J Biol Chem; 2001 May; 276(21):18551-6. PubMed ID: 11279033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human mast cell chymase by secretory leukocyte proteinase inhibitor: enhancement of the interaction by heparin.
    Walter M; Plotnick M; Schechter NM
    Arch Biochem Biophys; 1996 Mar; 327(1):81-8. PubMed ID: 8615699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the primary structures of human skin chymase and cathepsin G from cutaneous mast cells of urticaria pigmentosa lesions.
    Schechter NM; Wang ZM; Blacher RW; Lessin SR; Lazarus GS; Rubin H
    J Immunol; 1994 Apr; 152(8):4062-9. PubMed ID: 8144971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.